Adiposity and gastrointestinal malignancy

Digestion

Volumn 79, Issue SUPPL. 1, 2009, Pages 26-32

  Kitayama, Joji ^a   Tabuchi, Masafumi ^b   Tsurita, Giichiro ^a   Ishikawa, Makoto ^a   Otani, Kensuke ^a   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Nakameguro Gastrointestinal Clinic   (Japan)

Author keywords

Adiponectin; Colorectal cancer; Fat volume; Gastric cancer; Hyperlipidemia

Indexed keywords

ADIPONECTIN;

ADVANCED CANCER; BODY FAT; BODY MASS; CANCER GROWTH; COLON ADENOMA; COLORECTAL TUMOR; CONFERENCE PAPER; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LYMPH NODE METASTASIS; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH CANCER;

ADENOMA; ADIPONECTIN; ADIPOSITY; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; LYMPHATIC METASTASIS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS;

EID: 58549114183     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167863     Document Type: Conference Paper

References (39)

1. Armstrong B, Doll R: Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975;15:617-631.
2. Azevedo A, Ramos E, von Hafe P, Barros H: Upper-body adiposity and risk of myocardial infarction. J Cardiovasc Risk 1999;6:321-325.
3. Donahue RP, Abbott RD, Bloom E, Reed DM, Yano K: Central obesity and coronary heart disease in men. Lancet 1987;i:821-824.
4. Ducimetiere P, Richard J, Cambien F: The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: the Paris Prospective Study. Int J Obes 1986;10:229-240.
5. Lapidus L, Bengtsson C, Lissner L: Distribution of adipose tissue in relation to cardiovascular and total mortality as observed during 20 years in a prospective population study of women in Gothenburg, Sweden. Diabetes Res Clin Pract 1990;10(suppl 1):S185-S189.
6. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G: Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 1984;288:1401-1404.
7. Reeder BA, Senthilselvan A, Despres JP, Angel A, Liu L, Wang H, et al: The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group. Cmaj 1997;157(suppl 1):S39-S45.
8. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB: Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 1990;131:794-803.
9. Giovannucci E: Insulin and colon cancer. Cancer Causes Control 1995;6:164-179.
10. Hartz AJ, Rupley DC, Rimm AA: The association of girth measurements with disease in 32,856 women. Am J Epidemiol 1984;119:71-80.
11. Schapira DV, Kumar NB, Lyman GH, Cavanagh D, Roberts WS, LaPolla J: Upper-body fat distribution and endometrial cancer risk. JAMA 1991;266:1808-1811.
12. Lew EA, Garfinkel L: Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979;32:563-576.
13. Hill HA, Austin H: Nutrition and endometrial cancer. Cancer Causes Control 1996;7:19-32.
14. Hunter DJ, Willett WC: Nutrition and breast cancer. Cancer Causes Control 1996;7:56-68.
15. Kolonel LN: Nutrition and prostate cancer. Cancer Causes Control 1996;7:83-44.
16. Potter JD: Nutrition and colorectal cancer. Cancer Causes Control 1996;7:127-146.
17. Zatonski WA, Lowenfels AB, Boyle P, Maisonneuve P, Bueno de Mesquita HB, Ghadirian P, et al: Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst 1997;89:1132-1138.
18. Hansson LE, Nyren O, Bergstrom R, Wolk A, Lindgren A, Baron J, et al: Nutrients and gastric cancer risk: a population-based case-control study in Sweden. Int J Cancer 1994;57:638-644.
19. Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, et al: Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998;90:150-155.
20. Lagergren J, Bergstrom R, Nyren O: Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999;130:883-890.
21. Tabuchi M, Kitayama J, Nagawa H: Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men. World J Gastroenterol 2006;12:1261-1264.
22. Tabuchi M, Kitayama J, Nagawa H: Hyperglycemia and hypertriglyceridemia may associate with the adenoma-carcinoma transition in colorectal epithelial cells. J Gastroenterol Hepatol 2008;23:985-987.
23. Kitayama J, Hatano K, Kaisaki S, Suzuki H, Fujii S, Nagawa H: Hyperlipidaemia is positively correlated with lymph node metastasis in men with early gastric cancer. Br J Surg 2004;91:191-198.
24. Guerre-Millo M: Adipose tissue and adipokines: for better or worse. Diabetes Metab 2004;30:13-19.
25. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
26. Diez JJ, Iglesias P: The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148:293-300.
27. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-1599.
28. Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H: Plasma adiponectin and gastric cancer. Clin Cancer Res 2005;11:466-472.
29. Dal Maso L, Augustin LS, Karalis A, Talamini R, Franceschi S, Trichopoulos D, et al: Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 2004;89:1160-1163.
30. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, et al: Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003;9:5699-5704.
31. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S: Prostate cancer and adiponectin. Urology 2005;65:1168-1172.
32. Michalakis K, Williams CJ, Mitsiades N, Blakeman J, Balafouta-Tselenis S, Giannopoulos A, et al: Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomarkers Prev 2007;16:308-313.
33. Kang JH, Lee YY, Yu BY, Yang BS, Cho KH, Yoon DK, et al: Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res 2005;28:1263-1269.
34. Bub JD, Miyazaki T, Iwamoto Y: Adiponectin as a growth inhibitor in prostate cancer cells. Biochem Biophys Res Commun 2006;340:1158-1166.
35. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R: Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 2006;345:271-279.
36. Ishikawa M, Kitayama J, Yamauchi T, Kadowaki T, Maki T, Miyato H, et al: Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci 2007;98:1120-1127.
37. Otani K, Kitayama J, Kaisaki S, Ishigami H, Hidemura A, Fujishiro M, et al: Early gastric cancer shows different associations with adipose tissue volume depending on histological type. Gastric Cancer 2008;11:86-95.
38. Eguchi M, Tsuchihashi K, Saitoh S, Odawara Y, Hirano T, Nakata T, et al: Visceral obesity in Japanese patients with metabolic syndrome: reappraisal of diagnostic criteria by CT scan. Hypertens Res 2007;30:315-323.
39. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638.